Vascular aging in long-term survivors of testicular cancer more than 20 years after treatment with cisplatin-based chemotherapy

BACKGROUND: Late effects of cisplatin-based chemotherapy in testicular cancer survivors (TCS) include cardiovascular morbidity, but little data is available beyond 20 years. The objective was to assess vascular damage in very long-term TCS. METHODS: TCS (treated with chemotherapy or orchiectomy only...

Descripción completa

Detalles Bibliográficos
Autores principales: Stelwagen, Johannes, Lubberts, Sjoukje, Steggink, Lars C., Steursma, Gerrie, Kruyt, Lara M., Donkerbroek, Jan Willem, van Roon, Arie M., van Gessel, Anne I., van de Zande, Saskia C., Meijer, Coby, Gräfin zu Eulenburg, Christine H., Oosting, Sjoukje F., Nuver, Janine, Walenkamp, Annemiek M. E., Jan de Jong, Igle, Lefrandt, Joop D., Gietema, Jourik A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7686327/
https://www.ncbi.nlm.nih.gov/pubmed/32921790
http://dx.doi.org/10.1038/s41416-020-01049-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7686327/
https://www.ncbi.nlm.nih.gov/pubmed/32921790
http://dx.doi.org/10.1038/s41416-020-01049-3

Ejemplares similares